1. Home
  2. BZAI vs LUCD Comparison

BZAI vs LUCD Comparison

Compare BZAI & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blaize Holdings Inc.

BZAI

Blaize Holdings Inc.

HOLD

Current Price

$1.77

Market Cap

236.9M

Sector

N/A

ML Signal

HOLD

Logo Lucid Diagnostics Inc.

LUCD

Lucid Diagnostics Inc.

HOLD

Current Price

$1.34

Market Cap

190.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZAI
LUCD
Founded
2010
2018
Country
United States
United States
Employees
254
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
236.9M
190.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BZAI
LUCD
Price
$1.77
$1.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$5.50
$4.13
AVG Volume (30 Days)
7.3M
521.7K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$4,346,000.00
Revenue This Year
$239.02
$126.14
Revenue Next Year
$46.03
$138.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
79.00
52 Week Low
$1.00
$0.95
52 Week High
$6.76
$1.70

Technical Indicators

Market Signals
Indicator
BZAI
LUCD
Relative Strength Index (RSI) 54.32 63.83
Support Level $1.03 $1.01
Resistance Level $2.40 $1.52
Average True Range (ATR) 0.29 0.07
MACD 0.03 0.02
Stochastic Oscillator 47.49 83.33

Price Performance

Historical Comparison
BZAI
LUCD

About BZAI Blaize Holdings Inc.

Blaize Holdings Inc provides transformative artificial intelligence (AI)-enabled edge computing solutions comprised of both its proprietary hardware and software, and third-party hardware solutions. Its portfolio includes programmable AI processors in various form factors, which can be deployed across sectors such as smart cities, defense, retail, and enterprise markets. The company operates as a single operating and reportable segment. The majority of the company's revenue is derived from Hardware revenue, which includes the sale of its semiconductor products and/or third-party hardware products that support semiconductor products through various supply agreements. Geographically, it generates the maximum revenue from China.

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Share on Social Networks: